Source comparison
Stacking CJC-1295 Ipamorelin Anti-Aging: Protocol Comparison
CJC-1295 alone GHRH receptor agonism, sustained baseline GH 1–2× weekly Moderate (20–40 ng/mL increase) Minimal Moderate Effective for maintaining GH floor but lacks pulsatile amplitude needed for robust anabolic signaling. Best for maintenance, not optimizati
This comparison does not assign a generated winner or score.
- CJC-1295 alone
- GHRH receptor agonism, sustained baseline GH
- 1–2× weekly
- Moderate (20–40 ng/mL increase)
- Minimal
- Moderate
- Effective for maintaining GH floor but lacks pulsatile amplitude needed for robust anabolic signaling. Best for maintenance, not optimization
- Ipamorelin alone
- Ghrelin receptor agonism, sharp pulsatile GH
- Daily before sleep
- Moderate (30–50 ng/mL increase)
- None
- High
- Excellent for sleep and recovery but requires daily dosing and risks receptor desensitization without cycling. Limited long-term sustainability
- CJC-1295 + Ipamorelin stack
- Dual-receptor activation, sustained baseline + pulsatile spikes
- CJC 1–2× weekly, ipamorelin daily
- High (40–80 ng/mL increase)
- Very High
- Superior IGF-1 response, mimics youthful GH secretion patterns, maximizes collagen synthesis and recovery. The evidence-backed standard for anti-aging applications
- GHRP-6 + CJC-1295
- Dual-receptor but non-selective ghrelin agonism
- CJC 1–2× weekly, GHRP-6 2–3× daily
- High but variable
- Moderate (cortisol spikes common)
- Effective for GH release but cortisol and prolactin elevation make it suboptimal for anti-aging. Ipamorelin is the cleaner alternative